Skip to main content
Equibles
CAI logo

CAI · Caris Life Sciences, Inc.

Track CAI — free

Use CAI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CAI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$21.80 -0.38 (-1.71%) At close · Aug 14
Market Cap
$6.16B
Shares
282.60M

Caris Life Sciences, Inc. Earnings Call Transcripts

Every quarterly earnings call for Caris Life Sciences, Inc. (CAI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲81.3% $181.40M −$71.79M '25 Q2 25-08-12 ▲113.4% $216.83M $24.32M '25 Q3 25-11-05 · $292.89M $81.96M '25 Q4 26-02-26 ▲78.8% $216.17M −$510,000 '26 Q1 26-05-07 LATEST ▲45.4% $263.71M −$637,000 '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Caris Second Quarter 2026 Financial Results Conference Call
Confident tone Record clinical volume and case growth Reimbursement and coverage Financial performance and profitability
Revenue
$263.71M
▲ 45.4% YoY
Diluted EPS
$0.00
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Caris Life Sciences, Inc. Q1 FY2026 Earnings Call
Confident tone New product launches MRD pipeline MCED early detection and Everlywell partnership
Revenue
$216.17M
▲ 78.8% YoY
Diluted EPS
$0.00
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Caris Life Sciences, Inc. Q4 FY2025 Earnings Call
Confident tone Caris Detect / MCED Profitability and cash flow MI Cancer Seek launch and ASP
Revenue
$292.89M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Caris Life Sciences, Inc. Q3 FY2025 Earnings Call
Confident tone Whole Exome and Whole Transcriptome platform MRD and monitoring pipeline Revenue growth and case volumes
Revenue
$216.83M
▲ 113.4% YoY
Diluted EPS
$0.08
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Caris Life Sciences, Inc. Q2 FY2025 Earnings Call
Revenue
$181.40M
▲ 81.3% YoY
Diluted EPS
$-7.97
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts CIK 2019410 CUSIP 142152107 13F (30d) 232 filings 231 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)